Dietary Supplements

Lactobacillus gasseri LG-G12 Alleviates High-Fat Diet-induced Obesity through Gut Microbiota-Bile Acid Axis.

TL;DR

Lactobacillus gasseri LG-G12 ameliorates high-fat diet-induced obesity in mice via the gut microbiota-bile acid axis, which the authors present as making it a promising candidate for weight management.

Key Findings

L. gasseri LG-G12 showed gut colonization capacity and metabolic regulation potential in vitro.

  • The abstract reports these in vitro properties as the basis for selecting the strain for in vivo testing.
  • The abstract gives no quantitative in vitro data.

LG-G12 alleviated high-fat diet-induced weight gain and visceral fat accumulation in mice.

  • The effect was observed in vivo in a high-fat diet mouse model.
  • The abstract does not give effect sizes, group sizes, or p-values.

Fecal targeted metabolomics identified bile acid metabolism as a key pathway affected by LG-G12.

  • Targeted metabolomics was performed on fecal samples.
  • This finding led the authors to examine the gut microbiota-bile acid axis.

LG-G12 might exhibit bile salt hydrolase and hydroxysteroid dehydrogenase activities, contributing to a bile acid profile with low cholic acid and high ursodeoxycholic acid.

  • The abstract's wording is tentative ("might exhibit").
  • The resulting profile is low cholic acid (CA) and high ursodeoxycholic acid (UDCA).

LG-G12 increased the abundance of deoxycholic acid-producing Eubacterium spp., leading to elevated DCA levels.

  • The change in Eubacterium abundance is linked to higher deoxycholic acid (DCA).
  • This is described as an additional mechanism alongside the LG-G12 enzyme activities.

The altered bile acid profile activated FXR and TGR5 and was associated with reduced lipid accumulation and adipocyte differentiation in liver and epididymal adipose tissue, and with increased thermogenesis in brown adipose tissue.

  • FXR and TGR5 are bile acid receptors that were activated.
  • Reduced lipid accumulation and adipocyte differentiation were seen in liver and epididymal adipose tissue.
  • Brown adipose tissue showed promoted thermogenesis.

The authors conclude that LG-G12 ameliorates high-fat diet-induced obesity via the gut microbiota-bile acid axis.

  • The study was motivated by the controversy over probiotics in weight management.
  • The authors position LG-G12 as a promising candidate for weight management.

What This Means

This study tested a probiotic bacterial strain, Lactobacillus gasseri LG-G12, in mice fed a high-fat diet. Mice given the strain gained less weight and accumulated less belly (visceral) fat than expected on that diet. The question matters because the usefulness of probiotics for weight control is still debated. The researchers traced the effect to bile acids, which are digestive compounds made from cholesterol that also act as signals in the body. The strain appeared to change the bile acid mix in the gut, lowering cholic acid and raising ursodeoxycholic acid. It also increased gut bacteria that make deoxycholic acid. This new mix activated two bile acid sensors, FXR and TGR5, which was linked to less fat build-up in the liver and fat tissue and more heat production in brown fat. This research suggests that some probiotic strains may influence body weight by reshaping gut bile acids. The findings come from mice and cell experiments, and some enzyme activities were described only as possible. They do not show that the strain would cause weight loss in people, and human studies would be needed.

Check Your Own Numbers

Upload your bloodwork. We'll cross-reference your results against this study and 4,700 others.

Upload Your Labs

Have a question about this study?

Citation

Luo Y, Wu S, Li J, Ren L, Jia W, Yang M, et al.. (2026). Lactobacillus gasseri LG-G12 Alleviates High-Fat Diet-induced Obesity through Gut Microbiota-Bile Acid Axis.. Journal of agricultural and food chemistry. https://doi.org/10.1021/acs.jafc.6c03437